
Shingles manifests as a distinctive band-like rash that wraps around one side of the torso or face, accompanied by intense nerve pain. The term “shingles” (from the Latin *cingulum*, meaning belt) derives from this characteristic pattern. The virus spreads along affected nerve pathways, causing skin lesions.
In 70% to 80% of cases, patients experience prodromal symptoms before the rash appears, including stabbing or burning pain, itching, or flu-like symptoms such as muscle aches. These early signs can mimic a cold, complicating diagnosis. Within days, redness, papules, and blisters emerge, progressing to pustules and crusting over within two to three weeks.
While shingles is not highly contagious, the virus in blister fluid can transmit chickenpox to individuals without prior exposure, particularly through mucosal contact. Dr. Lee advises avoiding contact with infants, pregnant women, and immunocompromised individuals until the blisters scab over, as airborne transmission via coughing or sneezing does not occur.
PHN is particularly prevalent among older adults. Studies indicate that half of patients over 70 experience lingering pain a year after onset. Severe acute pain or lesions on the head or face heighten the risk of complications. Treatment for PHN focuses on pain relief through medications and conservative measures like nerve blocks.
Vaccination offers a powerful preventive tool. Older live vaccines had a modest 60% efficacy rate, but newer recombinant vaccines with adjuvants boast an average efficacy of 95%. Widely adopted in countries like the United States, these vaccines are recommended in South Korea by the Korean Society of Infectious Diseases for adults over 50 and immunocompromised individuals over 18.

medikorea team Lim Hye Jeong,
press@hinews.co.kr